Second infant formula toxin recall by FSA this month

Danone has recalled one batch of infant formula over the presence of the toxin cereulide, following a contamination from the same supplier that forced Nestlé to issue a recall earlier this month.

Danone said there were "low levels" of the toxin in the contaminated batch

The only affected Danone formula is the Aptamil First Infant Formula 800g product with a 31-10-2026 batch code that was on sale in the UK between May and July 2025, and Danone said it was recalling due to “low levels of cereulide”.

The Food Standards Agency (FSA) alert on January 24 urged to stop using the affected products and “if the infant formula was prescribed by a health professional for your infant, consult a pharmacist or other medical professional before changing formula”.

Read more: Pharmacies to ‘review’ baby formula stock amid toxin recall

FSA head of incidents Jodie Wild advised anyone with concerns to contact a GP or NHS 111 for advice.

Tracing

Wild added that ongoing investigations identified the contamination “originated from a shared third-party ingredient supplier”.

The FSA confirmed the affected ingredient is arachidonic acid (ARA) oil and it is the same supplier as the one that Nestlé had detected a “quality issue” with one of its leading suppliers.

On January 5, Nestlé issued recalls for 12 of its SMA infant formula and follow-on formula products across 37 countries worldwide.

Read more: ‘Discoloured’ paracetamol recalled over contamination fears

The possible contamination of cereulide makes the affected products “unsafe to consume” as symptoms include “nausea, vomiting and abdominal cramps”, according to the FSA.

It is “working urgently” with manufacturers to trace all products that may have used ingredients from this supplier, and “ensure all affected products are removed from sale”.

Read more: Supermarket cough medicines recalled over ‘foreign material’

It is also working with the UK Health Security Agency (UKHSA), local authorities and industry on “sampling where appropriate”.

The FSA does not confirm the identity of suppliers while investigations are ongoing.

It comes after the Medicines and Healthcare products Regulatory Agency (MHRA) revealed in June that a manufacturer had recalled two batches of paracetamol as a “precautionary measure due to contamination”.

Ben Lee

Read more by Ben Lee

Ben Lee joined C+D in June 2024 and writes news, features and interviews, as well as producing video and podcasts. He played an integral part in C+D winning the 2025 PPA Community Engagement Award.

Latest from Business

More from News